Background and Purpose: The precise mechanism of neurological symptoms with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is still controversial. We investigated the correlation between strokelike episodes and cerebral blood flow in two patients with MELAS and discuss the pathogenesis of strokelike episodes with MELAS.
*mitochondrial encephalomyopathy * tomography, showed an irregular low-density area in the left occipital lobe interlaced with contrast-enhanced lesions ( Figure  IA ). Cerebral angiography revealed dilation of the cortical arteries, capillary blush, and early venous filling in the left occipital lobe ( Figure IB) . The hemianopsia and the occipital radiolucency demonstrated on CT scan disappeared over 2 weeks.
One year later, the patient developed generalized clonic seizures that progressed to status epilepticus with generalized delta burst discharges on electroencephalography. The seizures were resistant to anticonvulsant therapy and lasted 5 days. Six months later, the patient developed anorexia and fatigability. Neurological examination showed a left hemiparesis and hemihypesthesia, and homonymous hemianopsia. CT scan revealed a large low-density area over the right parieto-occipital region in which the cortical surface was enhanced with contrast medium. Capillary blush and early venous filling were noted in this region by cerebral angiography. Magnetic resonance imaging (MRI) revealed prolongation of the Ti and T2 relaxation times in the affected cerebral cortex (Figures 2A and 2B) .
The patient's height was 140 cm, short stature for a 20-year-old woman. Lactic acidemia (38.8 mg/dl; normal value, 3.3-14.9 mg/dl) and pyruvic acidemia (1.21 mg/dl; normal, 0.30-0.94 mg/dl) were present. The cerebrospinal fluid (CSF) concentration of lactate and pyruvate also were elevated (51.2 mg/dl and 1.86 mg/dl, respectively). A biopsy specimen from the biceps brachii muscle showed scattered ragged red fibers by modified Gomori trichrome staining. Respiratory enzyme assay revealed that cytochrome c oxidase activity was abnor- Dynamic computed tomography (DCT) was performed according to the method of Terada et al. 6, 7 Time-density curves in the regions of interest were obtained from serial 24 rapid-sequence CT images during the first 50 seconds after an intravenous bolus injection of amidotrizoate sodium meglumine (Urografin). On the patient's first admission, 72 hours after the onset of neurological symptoms, DCT demonstrated that the peak height of the time-density curve was abnormally elevated in the lucent area seen on CT scan ( Figure IC) . The in the area of the lesion compared with the contralateral side. Two weeks later, no difference was noted between the right and left occipital lobes ( Figure 1D ).
On the patient's second admission, when she exhibited left-sided sensory and motor deficits for 6 hours, DCT showed identical findings in the right parietal cortex ( Figure 2C ). Three weeks later, the time-density curves were normal in the region. Figure 3A) . The lucent areas seen on MRI were not enhanced with gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) ( Figure 3B ).
The serum lactic acid concentration (29.2 mg/dl) and the pyruvic acid concentration (2.01 mg/dl) were elevated. The CSF lactate and pyruvate concentrations were also elevated (25.1 mg/dl and 1.27 mg/dl, respec-tively). Biopsy specimens of the biceps brachii muscle revealed ragged red fibers by modified Gomori trichrome staining.
Three hours after development of headache and right-sided homonymous hemianopsia, regional cerebral blood flow (rCBF) was evaluated by the xenonenhanced CT technique.8'9 The rCBF was 54.0 ml/100 g per minute in the lucent area of the left occipital cortex and 31.5 ml/100 g per minute in the corresponding contralateral region (normal value, 34.4+6.7 ml/100 g per minute). Functional rCBF mapping demonstrated increased rCBF in the left occipital cortex and hypoperfusion in the lucent areas of the basal ganglia ( Figure  3C ).
Discussion
The pathogenesis of strokelike episodes in patients with MELAS has not been determined. Some authors have suggested a nonvascular etiology for the neurological deficits because the cortical lesions usually do not correspond to anatomic vascular distributions and eventually disappear.10"'1 Recent pathological studies, however, have demonstrated a vascular abnormality, termed "mitochondrial angiopathy," in patients with MELAS.'2-14 Mitochondrial accumulation in the smooth muscle and endothelial cells of cerebral arteries has been postulated as a possible cause of the ischemic lesions in the brain.12"13
Both patients in this study had the radiological signs of MELAS, as described recently.15-18 The CT and MRI findings revealed that the shape and size of the infarctlike lesions in the cerebral cortex changed during the patients' clinical course. On CT scan, low-density areas showing cortical enhancement corresponded to regions of capillary blush on cerebral angiography.16 Despite strong enhancement on CT scan, the lucent areas seen on MRI were not enhanced with intravenous Gd-DTPA in case 2, which suggested that the blood-brain barrier was intact.
We examined cerebral circulation of our patients by DCT and xenon-enhanced CT scan within 72 hours after the onset of stroke-like episodes. The affected cortical area in case 2 showed an increase in rCBF by xenon-enhanced CT during the strokelike episodes. In case 1, the peak height on DCT was elevated without changing in the transit time. Because rCBF is a function of cerebral blood volume and transit time, increased rCBF in the affected area was most likely caused by an increase in cerebral blood volume.6'7"9 We also think that the increase in rCBF with MELAS is different from the luxury perfusion seen in the subacute phase of an ischemic stroke because serial cerebral blood flow studies failed to show an ischemic area throughout the patients' clinical course. We therefore assume that the transient increase in rCBF was caused by vasodilation due to metabolic acidosis localized in the affected cerebral cortex.
Recently some reports on the cerebral circulation in patients with MELAS have been published. In a single photon emission-computed tomographic (SPECT) study, [1231] iodoamphetamine (IMP) accumulated locally several days before the appearance of low-density areas on CT, suggesting increased rCBF with metabolic acidosis.20 However, defects on [1231]IMP SPECT were observed in the lucent areas seenn on CT scan. 21 The authors interpreted this as dysfunction of the capillary endothelium. Unlike the finding on SPECT studies, positron emission tomography (PET) studies have shown clearly metabolic dysfunction in brain tissue and thus support our hypothesis. Luxury perfusion of the cerebral cortex, appearing as increased cerebral blood flow, reduced cerebral metabolic rate of oxygen (CMRO2), and a lower oxygen extraction fraction (OEF), has been reported in a PET study on two patients with MELAS.22 Another PET study using ["C]pyruvate has shown an increase in the glycolytic metabolism of pyruvate in the brains of patients with mitochondrial encephalomyopathy having neurological deficits, in whom CMRO2 and OEF were decreased markedly.23 Based on these studies and our data, we propose that central nervous system dysfunction in MELAS is a result of metabolic dysfunction in the neural tissues rather than of ischemic stroke.
